Everyman Action Against Male Cancer
03166376
Some Concerns
- Negative net worth (-10)
Details
Compliance
Last accounts
31/07/2025
dormant
Next accounts due
30/04/2027
Confirmation statement
Last: 28/02/2026
Due 14/03/2027
Industry
Officers
director · Since 01/06/2010
ACCOUNTANT
BRITISH · ENGLAND · Age 58
Also on 6 other boards
director · Since 14/04/2023
CHIEF EXECUTIVE
DANISH · ENGLAND · Age 64
Also on 4 other boards
secretary · Since 24/04/2023
Persons with Significant Control
Institute Of Cancer Research: Royal Cancer Hospital (The) (Company Number 00534147)
Institute Of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
Reg: 00534147 · Companies House · Charitable Company Limited By Guarantee
Notified 13/03/2026
Former PSCs
Mr Stephen Rex Davie
Ceased 27/01/2021
Mr Peter John Charles Keemer
Ceased 25/02/2026
Mr Jonathan Mark Kipling
Ceased 25/02/2026
CompanyRankvs 54754+ SIC 86900 peers34
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/07/2025
Net Worth
£0
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
—
Working capital
Current Assets
—
Current Liabilities
—
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | NaN |
| 2023 | NaN |
Derived from filed accounts. Not audited figures.